Shulan Tian
Overview
Explore the profile of Shulan Tian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
8701
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pinto E Vairo F, Zimmermann M, Wagenknecht J, Jorge S, Tian S, Vierkant R, et al.
Hepatology
. 2025 Jan;
PMID: 39879586
Background Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects about a third of adults worldwide and is projected soon to be the leading cause of cirrhosis. It occurs when fat...
2.
Koleilat A, Tang H, Sharma N, Yan H, Tian S, Smadbeck J, et al.
Genet Med Open
. 2024 Dec;
1(1):100816.
PMID: 39669246
Purpose: Fluorescence in situ hybridization (FISH) is the current gold standard assay that provides information related to risk stratification and therapeutic selection for individuals with plasma cell neoplasms. The differential...
3.
Bandel L, Vierkant R, Kruisselbrink T, Bublitz M, Wilson T, Armasu S, et al.
Mayo Clin Proc
. 2024 Dec;
PMID: 39625429
Objective: To execute a large-scale, decentralized, clinical-grade whole exome sequencing study, coined Tapestry, for clinical practice, research discovery, and genomic education. Patients And Methods: Between July 1, 2020, and May...
4.
Dragojevic S, Smith E, Regan M, Stopka S, Baquer G, Xue Z, et al.
Mol Cancer Ther
. 2024 Oct;
PMID: 39440433
Glioblastoma (GBM) remains one of the most therapy-resistant malignancies with frequent local failures despite aggressive surgery, chemotherapy, and ionizing radiation (IR). Small molecule inhibitors of DNA-dependent protein kinase (DNA-PKi's) are...
5.
Tang H, Yan H, Shivaram S, Lehman S, Sharma N, Smadbeck J, et al.
Leukemia
. 2024 Oct;
39(1):42-50.
PMID: 39402215
Multiple myeloma (MM) is a plasma cell (PC) malignancy characterized by cytogenetic abnormalities, such as t(11;14)(q13;q32), resulting in CCND1 overexpression. The rs9344 G allele within CCND1 is the most significant...
6.
Laverty D, Gupta S, Bradshaw G, Hunter A, Carlson B, Calmo N, et al.
Nat Commun
. 2024 Jun;
15(1):5294.
PMID: 38906885
Determining the balance between DNA double strand break repair (DSBR) pathways is essential for understanding treatment response in cancer. We report a method for simultaneously measuring non-homologous end joining (NHEJ),...
7.
Wang H, Tian S, Secreto C, Sinha S, Shi M, Call T, et al.
Hematol Oncol
. 2024 Jun;
42(4):e3282.
PMID: 38852069
No abstract available.
8.
Udine E, DeJesus-Hernandez M, Tian S, das Neves S, Crook R, Finch N, et al.
Acta Neuropathol
. 2024 Apr;
147(1):73.
PMID: 38641715
The most prominent genetic cause of both amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) is a repeat expansion in the gene C9orf72. Importantly, the transcriptomic consequences of the...
9.
Liu Y, Wu Y, Jiang X, Chen B, Lu J, Cai Z, et al.
iScience
. 2023 Feb;
26(3):106100.
PMID: 36852272
Apolipoprotein H (APOH) is involved in lipid metabolism and functions as an acute-phase protein during hepatitis B virus (HBV) infection. Herein, we explored whether APOH acts on the development of...
10.
Charbonneau M, Harper K, Brochu-Gaudreau K, Perreault A, Roy L, Lucien F, et al.
Neuro Oncol
. 2023 Feb;
25(9):1605-1616.
PMID: 36821432
Background: High-grade gliomas (HGG) are aggressive brain tumors associated with short median patient survival and limited response to therapies, driving the need to develop tools to improve patient outcomes. Patient-derived...